Prostate-specific Antigen: Its Usefulness in Clinical Medicine (Q45876737)

17 December 2017

title

Prostate-specific Antigen: Its Usefulness in Clinical Medicine (English)

1 reference

17 December 2017

author

Eleftherios P. Diamandis

series ordinal

1

1 reference

17 December 2017

publication date

1 October 1998

1 reference

17 December 2017

Trends in Endocrinology and Metabolism

published in

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

310-316

1 reference

17 December 2017

Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Prostate-specific antigen and early detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Micrometastasis of prostate cancer to lymph nodes: detection by means of reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Clinical application of ultrasensitive prostate-specific antigen assays

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Prostate-specific antigen or human kallikrein 3? Recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Identity of Prostate Specific Antigen and the Semen Protein P30 Purified by a Rapid Chromatography Technique

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Isolation and Characterization of Two Specific Antigens of Human Seminal Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

A Comparison of 4 Ultrasensitive Prostate Specific Antigen Assays for Early Detection of Residual Cancer after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: correlation with histologic characteristics of the primary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Some comments on progress in the standardization of immunoassays for prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Detection of Prostate Cancer Relapse With Prostate Specific Antigen Monitoring at Levels of 0.001 to 0.1 micro g./l

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2898%2900082-4

7 January 2021

10.1016/S1043-2760(98)00082-4

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017